Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 08.01.2026 QJUN.LN IE000HFBJ0U0 3,400,002.00 USD 73,680,813.03 21.671  ...

OAKVILLE, Ontario--(BUSINESS WIRE)--Groupe de portefeuilles Harvest Inc. (« Harvest ») a le plaisir d’annoncer qu’à compter d’aujourd’hui, le FNB Harvest d’actions à revenu élevé MicroStrategy (TSX : MSTY) change de nom et devient le FNB Harvest d’actions à revenu élevé Strategy Inc. (TSX : MSTY). Le symbole boursier des parts de catégorie A de MSTY à la Bourse de Toronto (la « TSX ») demeure inchangé. Une demande a été soumise à la TSX afin que les parts de catégorie A du FNB soient négociées...

OAKVILLE, Ontario--(BUSINESS WIRE)--Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce that, effective today, the Harvest MicroStrategy High Income Shares ETF (TSX:MSTY) changed its name to Harvest Strategy Inc. High Income Shares ETF (TSX:MSTY). The trading symbol for the Class A units of MSTY listed on the Toronto Stock Exchange (the “TSX”) will not change. An application has been submitted to the TSX for the listed Class A units of the ETF to trade under the new name. Investmen...

DUBLIN--(BUSINESS WIRE)--The "Aircraft Machining Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2025-2032" report has been added to ResearchAndMarkets.com's offering. The aircraft machining market size was US$ 31.3 billion in 2024 and is likely to grow at a decent CAGR of 3.8% in the long run to reach US$ 43.6 billion in 2032 This report provides market intelligence most comprehensively. The report structure has been kept so that it offers maximum business va...

COLUMBUS, Ohio--(BUSINESS WIRE)--McGraw Hill, Inc. (NYSE: MH), a leading global provider for education solutions from preK-12 through higher education and professional learning, will report fiscal third quarter financial results for the period ended December 31, 2025, on Wednesday, February 11, 2026. The company will host a conference call via webcast beginning at 5:00 p.m. ET and will issue a press release reporting its results prior to the call. To access the listen only webcast, to view a re...

BOSTON--(BUSINESS WIRE)--Elucid today announced that, effective January 1, 2026, its Plaque-IQ™ coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT®) designation, alongside increasingly widespread coverage and reimbursement from both public and private payors. Together, these developments underscore the clinical value of coronary plaque analysis and establish favorable conditions for broader adoption of the technology. Quantitative coronary plaque analysis...

AUSTIN, Texas--(BUSINESS WIRE)--Sirion, ein weltweit führender Anbieter von Software für das Vertragslebenszyklusmanagement (Contract Lifecycle Management, CLM), gab heute bekannt, dass es eine endgültige Vereinbarung getroffen hat, wonach Haveli Investments, L.P. („Haveli” oder „Haveli Investments”), eine in Austin ansässige, auf Technologie spezialisierte Investmentgesellschaft, eine Mehrheitsbeteiligung an dem Unternehmen erwerben wird. Sirion unterstützt einige der weltweit größten Unterneh...

DUBLIN--(BUSINESS WIRE)--The "Aircraft Avionics MRO Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2025-2035" report has been added to ResearchAndMarkets.com's offering. The aircraft avionics MRO market size was valued at US$7.1 billion in 2024 and is expected to reach US$10.3 billion by 2035, growing at a CAGR of 3.8% during the forecast period. The aircraft avionics MRO market is experiencing strong growth, fueled by multiple factors reshaping the aviation industry. Ri...

BEIJING & ALAMEDA, Calif. & TAIPEI, Taiwan--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to ob...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced a series of corporate and pipeline updates. GCTx unveiled its initial pipeline programs focused on demyelinating neurological disorders, including multiple sclerosis (MS), and a regenerative cell therapy program for metabolic diseases, including Type 1 Diabetes. B...